Command Palette

Search for a command to run...

SMSPHARMA
277.51(+1.04%)
1W: +11.80%

SMS Pharmaceuticals Peer Comparison

Snapshot Summary

SMS Pharmaceuticals Ltd. shows promising growth metrics but is positioned within a competitive landscape where peers excel in profitability and efficiency. The company demonstrates solid revenue growth, yet its valuation metrics suggest it may be on the higher end compared to some peers with stronger margins and lower valuations.

  • SMS Pharmaceuticals shows the highest revenue growth YoY (35.86%) among its peers.
  • Cipla Ltd. stands out with the best profitability metrics, including ROE (16.63%) and ROA (13.59%).
  • Divi's Laboratories and Sun Pharmaceuticals are considered overvalued based on high PE and PBV ratios.
  • Cipla Ltd.: Best profitability metrics, solid revenue growth, and attractive PE ratio.
  • Dr. Reddy's Laboratories Ltd.: Strong ROE and ROCE while maintaining low debt levels.
  • Mankind Pharma Ltd.: High revenue growth trajectory and robust profitability ratios.
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
SMSPHARMA₹237.90₹2,109.03Cr30.8411.73%0.55
SUNPHARMA₹1,563.35₹3,75,099.26Cr87.5917.60%0.04
DIVISLAB₹6,091.05₹1,61,698.50Cr73.2016.46%-
CIPLA₹1,587.60₹1,28,217.27Cr23.7322.77%0.01
TORNTPHARM₹3,581.55₹1,21,215.77Cr61.5324.28%0.57
DRREDDY₹1,280.30₹1,06,835.27Cr15.5026.86%0.07
MANKIND₹2,518.95₹1,03,926.59Cr55.1828.38%0.02

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.